Applications
Sonus Microsystems' AI-driven ultrasound technology improves remote monitoring and diagnostic precision for conditions like congestive heart failure and hypertrophic cardiomyopathy.
sonusmicrosystems.comCrawled Nov 4, 2026
Sonus Microsystems' AI-driven ultrasound technology improves remote monitoring and diagnostic precision for conditions like congestive heart failure and hypertrophic cardiomyopathy.
Autonomous ultrasound patch under development, designed to support repeatable in-clinic cardiac function assessment (including LVEF) for cardio-oncology monitoring during potentially cardiotoxic therapy. Enrolling clinical partner sites.
Sonus Microsystems' polymer transducer technology enables the development of a wearable echocardiogram.
Echocardiography, a non-invasive imaging tool, is underused in hospitals despite evidence that it reduces mortality and improves outcomes for heart disease patients.
Recent research, including a prospective clinical study at the PRIME Centre at BC Women’s Hospital, sheds light on the importance of the placenta in fetal development.
How AI-powered ultrasound is changing medical imaging, expanding healthcare beyond hospitals and opening new possibilities for patient monitoring.
Ultrasound remains one of the most widely used imaging modalities in medicine. It’s real-time, radiation-free, and comparatively cost-effective. Yet as clinical expectations rise, innovation pressure across the entire ultrasound stack, from software to sensors, has been squeezed as well.
Download Sonus Microsystems' images and video for use in media coverage.
Sonus Microsystems collaborates with researchers at The University of British Columbia to develop advanced ultrasound sensors using their proprietary polyCMUT technology, supported by an Innovate BC IGNITE grant.
Sonus Microsystems develops a cardiac ultrasound patch to advance heart disease diagnosis and management.
Sonus Microsystems develops the first wearable cardiac ultrasound for congestive heart failure using their proprietary polymer transducer technology.
Sonus Microsystems is developing the first wearable cardiac ultrasound patch for congestive heart failure using unique polymer ultrasound transducers.
Sonus Microsystems and Medtronic are developing a non-invasive monitoring system for preeclampsia by integrating Sonus Patch—an AI-powered wearable ultrasound platform—with Medtronic’s Acute Care and Monitoring technology. The partnership will test the combined system in field studies conducted in Kenya.
Medtronic and Sonus Microsystems collaborate to integrate AI-driven ultrasound technology with Medtronic’s vital-sign monitoring systems. The partnership leverages Sonus’ ultrasound AI platform to enhance pregnancy monitoring capabilities. The project is backed by funding from the Gates Foundation.
A wearable ultrasound patch designed for continuous heart monitoring advances toward clinical trials. Providence Health Care Ventures (PHCV) and angel investors—including cardiac physicians—are funding the development. The device aims to improve heart failure management through real-time cardiac data.
Canadian developers of an autonomous ultrasound device are partnering to assess a wearable diagnostic patch, which they describe as a potential breakthrough in medical imaging. The collaboration aims to explore clinical applications of the technology, positioning it as a transformative tool for early disease detection. The project builds on existing advancements in portable, non-invasive diagnostic solutions.
Sonus Microsystems develops a patch-based cardiac ultrasound device that provides real-time, AI-enhanced imaging for use beyond hospital environments. The technology aims to improve accessibility of high-resolution cardiac diagnostics in non-clinical settings. Providence Health Care Ventures partners with Sonus to advance this innovation.
Sonus Microsystems collaborates with Providence Health Care Ventures to develop and validate its wearable ultrasound patch for cardiac monitoring. The partnership supports Sonus’ innovation under Providence’s new Innovation Program, aiming to integrate wearable cardiac ultrasound technology into clinical workflows. This marks the first collaboration under the newly launched initiative.